We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
InflaRx
IFRX
$256M
| $145K | ﹤0.01% |
+34,045
| New | +$157K |
|
2202
Liberty Latin America Class A
LILA
$1.51B
| $145K | ﹤0.01% |
+25,788
| New | +$157K |
|
|
GEN
2203
DELISTED
Genesis Healthcare, Inc.
GEN
| $145K | ﹤0.01% |
266,557
+164,861
| +162% | +$119K |
|
2204
Entravision Communication
EVC
$983M
| $144K | ﹤0.01% |
94,630
+47,591
| +101% | +$68.4K |
|
2205
Pluri
PLUR
$19.2M
| $144K | ﹤0.01% |
1,711
-80
| -4% | -$6.12K |
|
2206
Ribbon Communications
RBBN
$354M
| $144K | ﹤0.01% |
+37,267
| New | +$157K |
|
2207
Genco Shipping & Trading
GNK
$1.17B
| $143K | ﹤0.01% |
+20,759
| New | +$140K |
|
2208
Mayville Engineering Co
MEC
$772M
| $143K | ﹤0.01% |
+15,564
| New | +$131K |
|
2209
Passage Bio
PASG
$15.9M
| $143K | ﹤0.01% |
+544
| New | +$187K |
|
2210
Alaunos Therapeutics
TCRT
$4.74M
| $142K | ﹤0.01% |
375
-391
| -51% | -$173K |
|
|
TESS
2211
DELISTED
Tessco Technologies Inc
TESS
| $142K | ﹤0.01% |
+26,456
| New | +$164K |
|
2212
InfuSystem Holdings
INFU
$184M
| $140K | ﹤0.01% |
+10,907
| New | +$142K |
|
|
SEAC
2213
DELISTED
Seachange International Inc
SEAC
| $139K | ﹤0.01% |
7,976
+5,333
| +202% | +$141K |
|
|
AUMN
2214
DELISTED
Golden Minerals Company
AUMN
| $138K | ﹤0.01% |
+13,138
| New | +$146K |
|
|
OTIC
2215
DELISTED
Otonomy, Inc.
OTIC
| $136K | ﹤0.01% |
+33,642
| New | +$127K |
|
|
MRLN
2216
DELISTED
Marlin Business Services Corp
MRLN
| $135K | ﹤0.01% |
+19,134
| New | +$139K |
|
2217
electroCore
ECOR
$51.4M
| $134K | ﹤0.01% |
5,163
-253
| -5% | -$6.37K |
|
|
GV
2218
DELISTED
Goldfield Corporation
GV
| $134K | ﹤0.01% |
+31,564
| New | +$128K |
|
2219
Flex
FLEX
$43.4B
| $133K | ﹤0.01% |
15,813
-122,405
| -89% | -$998K |
|
|
BIOR
2220
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $133K | ﹤0.01% |
+59
| New | +$133K |
|
2221
Biomerica
BMRA
$4.88M
| $132K | ﹤0.01% |
2,380
+650
| +38% | +$42K |
|
2222
Medallion Financial
MFIN
$226M
| $131K | ﹤0.01% |
+52,284
| New | +$153K |
|
2223
Mammoth Energy Services
TUSK
$132M
| $131K | ﹤0.01% |
81,781
-5,356
| -6% | -$7.89K |
|
|
FABC
2224
Fabric.AI Inc
FABC
$16.8M
| $129K | ﹤0.01% |
+341
| New | +$166K |
|
2225
Soligenix
SNGX
$5.5M
| $129K | ﹤0.01% |
+300
| New | +$148K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.